Recursion Pharmaceuticals
RXRX
$9.48
Share price
10.23%
Change (1 day)
69.29%
Change (1 year)
Categories
Market capitalization of Recursion Pharmaceuticals (RXRX)
Market cap: $2.25 Billion
As of May 2024 Recursion Pharmaceuticals has a market cap of $2.25 Billion. This makes Recursion Pharmaceuticals the world's 3936th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Recursion Pharmaceuticals from 2021 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.25 B | 5.85% |
| 2023 | $2.12 B | 45.64% |
| 2022 | $1.46 B | -49.51% |
| 2021 | $2.89 B |
End of Day market cap according to different sources
On May 13th, 2024 the market cap of Recursion Pharmaceuticals was reported to be:
$2.25 Billion
$2.25 Billion
$2.25 Billion
$2.18 Billion